Jump to main content.


Research Project Search
 Enter Search Term:
   
 NCER Advanced Search

2004 Progress Report: Mechanisms of Particulate-Induced Allergic Asthma

EPA Grant Number: R832139C003
Subproject: this is subproject number 003 , established and managed by the Center Director under grant R832139
(EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).

Center: Johns Hopkins Center for Childhood Asthma in the Urban Environment
Center Director: Breysse, Patrick
Title: Mechanisms of Particulate-Induced Allergic Asthma
Investigators: Wills-Karp, Marsha
Institution: Johns Hopkins University
EPA Project Officer: Fields, Nigel
Project Period: November 1, 2003 through October 31, 2008
Project Period Covered by this Report: November 1, 2003 through October 31, 2004
RFA: Centers for Children's Environmental Health and Disease Prevention Research (2003)
Research Category: Children's Health , Health Effects

Description:

Objective:

The objectives of this research project are to: (1) establish a causal relationship between particulate matter (PM) exposure and asthma morbidity; and (2) determine the mechanisms by which PM elicits these effects.

Progress Summary:

To date, we have determined that a single (0.5 mg/mouse) intratracheal dose of PM collected in urban Baltimore induces significant increases in airway hyperresponsiveness (AHR), which is sustained over a 7-day period, returning to control levels at 14 days. The increase in AHR was preceded by dramatic increases in bronchoalveolar lavage granulocytes, particularly eosinophils. These physiological changes were associated with an early Th2 cytokine pattern (IL-5, IL-13, eotaxin), which shifted toward a Th1 pattern as AHR and granulocytes returned to normal levels. When the effects of ambient urban Baltimore (AUB) particulates were compared to two reference coal fly ash particulates, we found that AUB induced far more dramatic effects on AHR and airway inflammation than either of the reference particles. Finally, in a leaching experiment, we found that the active components of AUB are not water soluble, but remain particle-bound. We concluded from these studies that ambient PM can induce asthma-like parameters in naive mice, suggesting that PM exposure may contribute to increases in asthma prevalence.

As we recently have identified complement as a susceptibility gene for asthma in a murine model, we evaluated its role in PM-induced AHR. The responses to PM exposure were compared in complement factor 3 (C3)-deficient mice and their wild-type controls. Interestingly, C3-deficient mice did not develop AHR, whereas the wild-type mice developed significant AHR in response to particulate exposure. Immunostaining of lung sections with a fluorescent-labeled anti-C3 antibody revealed that C3 was deposited along the epithelial surface and in the smooth muscle layer. Thus, complement deposition may be a common mechanism by which airborne particles elicit allergic airway responses.

In another experiment, we compared the effects of PM collected in urban Baltimore with PM that was collected at the site of the World Trade Center (WTC) on September 11, 2001. Interestingly, although WTC PM elicited inflammation, it did not induce AHR as was observed with ambient Baltimore PM. Further characterization of the two sources of PM may reveal causative components of the Baltimore PM.

Because of these findings, we have proposed adding the following specific objectives:

Findings, Relevance to Field

Our findings have several implications to the field of asthma. First, to our knowledge, they are the first studies to demonstrate that ambient particulates can directly induce the symptoms of asthma. Second, our finding that particulates induce C3 activation may provide a potential mechanism by which particulates induce AHR and inflammation as well as provide a potential therapeutic target.

Future Activities:

Our plans during the next 6 months include further study of the role of indoor particulates in PM-induced allergic airway responses. We plan to determine the source of C3 production as well as the potential mechanisms by which C3 may be cleaved.

In addition, we plan to collect PM by similar means as the AUB from indoor sources in inner-city homes and possibly from either a rural source or a source enriched for diesel particles such as the truck-only lane of the Baltimore Fort McHenry Tunnel. A comparison of different sources of the PM may provide further information regarding the biologically active components of the AUB.


Journal Articles on this Report: 5 Displayed | Download in RIS Format

Other subproject views: All 11 publications 11 publications in selected types All 11 journal articles
Other center views: All 39 publications 39 publications in selected types All 38 journal articles

Type Citation Sub Project Document Sources
Journal Article Barnes KC, Caraballo L, Munoz M, Zambelli-Weiner A, Ehrlich E, Burki M, Jimenez S, Mathias RA, Stockton ML, Deindl P, Mendoza L, Hershey GK, Nickel R, Wills-Karp M. A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populations. Clinical and Experimental Allergy 2004;34(5):736-744. R832139 (2004)
R832139 (2005)
R832139C003 (2004)
  • Abstract from PubMed
  • Journal Article Hawlisch H, Wills-Karp M, Karp CL, Kohl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Molecular Immunology 2004;41(2-3):123-131. R832139 (2004)
    R832139 (2005)
    R832139C003 (2004)
  • Abstract from PubMed
  • Journal Article Polack FP, Teng MN, Collins PL, Prince GA, Exner M, Regele H, Lirman DD, Rabold R, Hoffman SJ, Karp CL, Kleeberger SR, Wills-Karp M, Karron RA. A role for immune complexes in enhanced respiratory syncytial virus disease. Journal of Experimental Medicine 2002;196(6):859-865. R832139 (2004)
    R832139 (2005)
    R832139C003 (2004)
  • Abstract from PubMed
  • Full-text: JEM Full Text
    Exit EPA Disclaimer
  • Other: JEM PDF
    Exit EPA Disclaimer
  • Journal Article Walters DM, Breysse PN, Schofield B, Wills-Karp M. Complement factor 3 mediates particulate matter–induced airway hyperresponsiveness. American Journal of Respiratory Cell and Molecular Biology 2002;27(4):413-418. R832139 (2004)
    R832139 (2005)
    R832139C003 (2004)
  • Abstract from PubMed
  • Full-text: ATS Full Text
    Exit EPA Disclaimer
  • Other: ATS PDF
    Exit EPA Disclaimer
  • Journal Article Wills-Karp M, Ewart SL. Time to draw breath: asthma-susceptibility genes are identified. Nature Reviews Genetics 2004;5(5):376-387. R832139 (2004)
    R832139 (2005)
    R832139C003 (2004)
  • Abstract from PubMed
  • Supplemental Keywords:

    particulate matter, PM, airway hyperresponsiveness, AHR, asthma, complement factor 3, C3, children’s health, Baltimore, , HUMAN HEALTH, Air, Geographic Area, Scientific Discipline, Health, RFA, PHYSICAL ASPECTS, Health Effects, Health Risk Assessment, Physical Processes, particulate matter, Allergens/Asthma, State, Maryland (MD), allergens, children's health, air toxics, respiratory, air pollution, airborne pollutants, children, exposure, asthma triggers, asthma, human exposure, PM

    Progress and Final Reports:
    Original Abstract
    2005 Progress Report


    Main Center Abstract and Reports:
    R832139    Johns Hopkins Center for Childhood Asthma in the Urban Environment

    Subprojects under this Center: (EPA does not fund or establish subprojects; EPA awards and manages the overall grant for this center).
    R832139C001 The Epidemiology of Susceptibility to Airborne Particulates and Allergens to Asthma in African Americans
    R832139C002 A Randomized Controlled Trial of Behavior Changes in Home Exposure Control
    R832139C003 Mechanisms of Particulate-Induced Allergic Asthma
    R832139C004 Dendritic Cell Activation by Particulate Matter and Allergen

    Top of page

    The perspectives, information and conclusions conveyed in research project abstracts, progress reports, final reports, journal abstracts and journal publications convey the viewpoints of the principal investigator and may not represent the views and policies of ORD and EPA. Conclusions drawn by the principal investigators have not been reviewed by the Agency.


    Local Navigation


    Jump to main content.